NEW YORK (GenomeWeb) – A clinical evaluation of a multiplexed assay from Enigma Diagnostics for influenza and respiratory syncytial virus has shown that the test might be useful at the point of care.
Published in November in the Journal of Clinical Microbiology, the study evaluated the MiniLab Influenza A/B & RSV assay on a treatment ward in the 154-bed Evelina Children's Hospital in central London.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
